Company intelligence / Profile preview

Alef Biotechnology

Santiago, Santiago Metropolitan Region, Chile

Ownership: Private
Development stage: Other

Overview

Alef Biotechnology is licensed by the Chilean government to produce and distribute medical cannabis, partnering with international pharmas to bring GMP-certified products to Latin American markets. The company has commercial-stage activities but clinical trial outcomes are not independently publicized.

Therapeutic areas: OncologyNeurologyOther
Modalities: Plant-derived product
Industry: Biotech

Partnerships

Tilray

Beyond the preview

Go deeper on Alef Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alef Biotechnology.

Explore the full profile